Acute ischemic stroke in the very elderly Chinese: Risk factors, hospital management and one-year outcome

Clinical Neurology and Neurosurgery

Volumn 113, Issue 6, 2011, Pages 442-446

  Wang, Deren ^a   Hao, Zilong ^a   Tao, Wendan ^a   Kong, Fanyi ^a   Zhang, Shihong ^a   Wu, Bo ^a   Lin, Sen ^a   Liu, Ming ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Acute ischemic stroke; Chinese; Elderly; Management; Outcome; Risk factor

Indexed keywords

ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD CLOT LYSIS; BLOOD VESSEL OCCLUSION; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DISEASE SEVERITY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATIENT CARE; PROSPECTIVE STUDY; SMOKING; TRANSIENT ISCHEMIC ATTACK; TRANSTHORACIC ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE; VERY ELDERLY;

AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN ISCHEMIA; CAUSE OF DEATH; CHINA; DISABILITY EVALUATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VASCULAR DISEASES;

EID: 79958144395     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2011.01.005     Document Type: Article

References (35)

1. Rothwell PM, Coull AJ, Silver LE, Fairhead JF, Giles MF, Lovelock CE, et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005;366:1773-83. (Pubitemid 41642641)
2. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006;37:577-617. (Pubitemid 43732031)
3. Canada S. Portrait of the Canadian population in 2006, 2006 census population and dwelling counts, 2006 census. Ottawa: Statistics Canada; 2007.
4. Follow-up investigation of Chinese urban and rural elderly population. http://www.china.com.cn/news/txt/2007-12/17/content 9392818.htm 2007.
5. Wenger NK. Enrollment and maintenance of elderly patients in cardiovascular clinical trials. Am J Geriatr Cardiol 2006;15:352-6.
6. Tanne D, Gorman MJ, Bates VE, Kasner SE, Scott P, Verro P, et al. Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older: the tPA stroke survey experience. Stroke 2000;31:370-5. (Pubitemid 30078168)
7. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29.
8. Hacke W, Furlan AJ, Al-Rawi Y, Davalos A, Fiebach JB, Gruber F, et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009;8:141-50.
9. Mateen FJ, Nasser M, Spencer BR, Freeman WD, Shuaib A, Demaerschalk BM, et al. Outcomes of intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 90 years or older. Mayo Clin Proc 2009;84:334-8.
10. Meseguer E, Labreuche J, Olivot JM, Abboud H, Lavallee PC, Simon O, et al. Determinants of outcome and safety of intravenous rt-PA therapy in the very old: a clinical registry study and systematic review. Age Ageing 2008;37:107-11. (Pubitemid 351146986)
11. Engelter ST, Reichhart M, Sekoranja L, Georgiadis D, Baumann A, Weder B, et al. Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis. Neurology 2005;65:1795-8.
12. Chen ZM, Sandercock P, Pan HC, Counsell C, Collins R, Liu LS, et al. Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40 000 randomized patients from the Chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. Stroke 2000;31:1240-9. (Pubitemid 30351240)
13. Saposnik G, Cote R, Phillips S, Gubitz G, Bayer N, Minuk J, et al. Stroke outcome in those over 80: a multicenter cohort study across Canada. Stroke 2008;39:2310-7.
14. Di Carlo A, Lamassa M, Pracucci G, Basile AM, Trefoloni G, Vanni P, et al. Stroke in the very old: clinical presentation and determinants of 3-month functional outcome: a European perspective. European BIOMED Study of Stroke Care Group. Stroke 1999;30:2313-9. (Pubitemid 29517728)
15. Denti L, Scoditti U, Tonelli C, Saccavini M, Caminiti C, Valcavi R, et al. The poor outcome of ischemic stroke in very old people: a cohort study of its determinants. J Am Geriatr Soc 2010;58:12-7.
16. Liebetrau M, Steen B, Skoog I. Stroke in 85-year-olds: prevalence, incidence, risk factors, and relation to mortality and dementia. Stroke 2003;34:2617-22. (Pubitemid 37392753)
17. Olindo S, Cabre P, Deschamps R, Chatot-Henry C, Rene-Corail P, Fournerie P, et al. Acute stroke in the very elderly: epidemiological features, stroke subtypes, management, and outcome in Martinique, French West Indies. Stroke 2003;34:1593-7. (Pubitemid 36842607)
18. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ 1980;58:113-30. (Pubitemid 10013261)
19. Kong FYTW, Hao ZL, Liu M. Predictors of one-year disability and death in Chinese hospitalized women after ischemic stroke. Cerebrovasc Dis 2010;29:255-62.
20. Brott T, Adams Jr HP, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:864-70. (Pubitemid 19188240)
21. Adams Jr HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
22. de Haan R, Limburg M, Bossuyt P, van der Meulen J, Aaronson N. The clinical meaning of Rankin 'handicap' grades after stroke. Stroke 1995;26:2027-30.
23. Saposnik G, Black S. Stroke in the very elderly: hospital care, case fatality and disposition. Cerebrovasc Dis 2009;27:537-43.
24. Marini C, Baldassarre M, Russo T, De Santis F, Sacco S, Ciancarelli I, et al. Burden of first-ever ischemic stroke in the oldest old: evidence from a population-based study. Neurology 2004;62:77-81. (Pubitemid 38082874)
25. Ovbiagele B, Hills NK, Saver JL, Johnston SC. Secondary-prevention drug prescription in the very elderly after ischemic stroke or TIA. Neurology 2006;66:313-8. (Pubitemid 43739929)
26. Yannick Bejot OR, Agnes Jacquin, Guy-Victor Osseby, Jerome Durier. Stroke in the very old: incidence, risk factors, clinical features, outcomes and access to resources-a 22-year population-based study. Cerebrovasc Dis 2010;29:111-21.
27. Chang KC, Lee HC, Tseng MC, Huang YC. Three-year survival after first-ever ischemic stroke is predicted by initial stroke severity: a hospital-based study. Clin Neurol Neurosurg 2010;112:296-301.
28. Lee M, Huang WY,Weng HH, Lee JD, Lee TH. First-ever ischemic stroke in very old Asians: clinical features, stroke subtypes, risk factors and outcome. Eur Neurol 2007;58:44-8. (Pubitemid 47038160)
29. Simpson CR, Wilson C, Hannaford PC, Williams D. Evidence for age and sex differences in the secondary prevention of stroke in Scottish primary care. Stroke 2005;36:1771-5. (Pubitemid 41098777)
30. Raine R, Wong W, Ambler G, Hardoon S, Petersen I, Morris R, et al. Sociodemographic variations in the contribution of secondary drug prevention to stroke survival at middle and older ages: cohort study. BMJ 2009;338:b1279.
31. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293-304.
32. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
33. Sivenius J, Riekkinen Sr PJ, Laakso M. Antiplatelet treatment in elderly people with transient ischaemic attacks or ischaemic strokes. BMJ 1995;310:25-6.
34. Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007;370:493-503. (Pubitemid 47212371)
35. Teramoto S. Novel preventive and therapuetic strategy for post-stroke pneumonia. Expert Rev Neurother 2009;9:1187-200.